SKI Market

A+| A| A-|

Indian Indices

Sensex

76,488.96 1,073.61
( 1.42%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

49.9768362

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

37.69

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	89.91	131.37	207.01	348.67	154.28	126.83
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	89.91	131.37	207.01	348.67	154.28	126.83
Other Income	2.44	0.84	9.84	0.95	0.75	0.42
Stock Adjustments	3.39	6.74	4.22	4.47	4.30	0.59
Total Income	95.74	138.95	221.07	354.09	159.33	127.84
EXPENDITURE :
Raw Materials	63.98	93.93	151.12	234.49	108.26	89.56
Power & Fuel Cost	3.25	3.61	5.99	5.68	4.88	3.66
Employee Cost	14.45	15.90	20.27	18.32	14.35	7.10
Other Manufacturing Expenses	1.36	0.91	1.85	2.96	1.60	1.03
Selling & Administrative Expenses	10.58	13.04	18.21	23.49	13.56	10.60
Miscellaneous Expenses	1.15	2.89	2.12	2.65	0.59	3.04
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	94.77	130.28	199.56	287.60	143.24	114.99
Operating Profit	0.97	8.66	21.51	66.49	16.08	12.85
Interest	7.64	9.77	10.92	8.31	3.98	3.22
Gross Profit	-6.67	-1.11	10.59	58.18	12.10	9.63
Depreciation	6.27	7.75	8.52	5.12	2.24	1.23
Profit Before Tax	-12.94	-8.86	2.07	53.06	9.86	8.40
Tax	0.00	0.00	2.11	13.47	3.18	2.40
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-2.59	-0.22	0.62	-0.11	-0.57	-0.09
Reported Net Profit	-10.34	-8.65	-0.66	39.71	7.25	6.10
Extraordinary Items	-0.45	-1.56	-0.27	0.00	0.00	0.00
Adjusted Net Profit	-9.89	-7.09	-0.39	39.71	7.25	6.10
Adjustment below Net Profit	0.08	0.19	0.72	0.21	-0.70	-0.26
P & L Balance brought forward	59.02	63.16	63.10	24.22	17.67	13.03
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	-4.33	0.00	1.04	0.00	0.00
P & L Balance carried down	48.76	59.02	63.16	63.10	24.22	18.87
Dividend	0.00	0.00	0.00	1.04	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	10.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	1.00	0.00	0.00
Earnings Per Share-Unit Curr	-7.92	-6.62	-0.51	38.31	13.99	11.76
Earnings Per Share(Adj)-Unit Curr	-7.92	-6.62	-0.51	30.65	5.60	4.70
Book Value-Unit Curr	50.88	58.74	61.91	76.00	76.99	66.67
Book Value(Adj)-Unit Curr	50.88	58.74	61.91	60.80	30.80	26.67

76,488.96 1,073.61 ( 1.42%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)